R&D Changing Faces: Pharma and biotech November-December 2024 Welcome to the last edition of Changing Faces for 2024.
News Trump puts final piece in his MAHA puzzle with NIH nominee President-elect Donald Trump has chosen Stanford health economist Dr Jay Bhattacharya to lead the NIH
News Makary confirmed as Trump's FDA pick, with Weldon for CDC Martin Makary has been confirmed as Donald Trump's pick for FDA Commissioner, while Dave Weldon has been selected as his pick for CDC Director
News Pfizer elevates Chris Boshoff to top R&D role Pfizer has named chief oncology officer Dr Chris Boshoff to the new role of chief of R&D
News BenevolentAI CEO steps down as founders make a comeback Jörg Möller's sojourn as chief executive of BenevolentAI has come to an abrupt end after just nine months, as the company names co-founder Ken Mulvany as its executive chairman.
Sales & Marketing Changing Faces – Board appointments September 2024 September brought numerous noteworthy appointments to boards of directors and advisory boards in the pharma, biotech, and agency worlds.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
